← Scroll for more →
Harmony Biosciences Holdings, Inc. (HRMY)
Pharmaceutical Preparations
Latest Price
$38.76
TTM P/E
12.58
Normalized P/E
14.69
TTM Div Yield
--
Fwd Div Yield
--
Book Value
17.26
P/B Ratio
2.25
Valuation metrics
adjust assumptions →EPS: $2.71
Book value / share: $15.07
Formula: √(22.5 × EPS × BVPS)
Graham Number
$30.32
22% downside
Norm. op. income: $156M (median of 6yr)
Tax rate: 25%
Discount rate: 10%
Growth assumption: zero (EPV is a no-growth value)
Earnings Power Value
$30.82
20% downside
Base FCF: $219M (median of recent 5yr)
Growth: 25%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$292.51
+655% upside
EPS: $2.71
Target P/E: 15×
Formula: EPS × P/E
P/E Fair Value
$40.65
+5% upside
Institutional Ownership
92.8% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 7.10M | $258.0M | 12.22% | +31.9K | 2026-06-30 |
| FMR LLC | 3.57M | $130.0M | 6.15% | +416.5K | 2026-06-30 |
| Vanguard Portfolio Management LLC | 2.88M | $104.0M | 4.96% | +166.1K | 2026-06-30 |
| American Century Companies Inc | 2.54M | $92.0M | 4.37% | +434.3K | 2026-06-30 |
| Dimensional Fund Advisors LP | 2.39M | $87.0M | 4.12% | +317.1K | 2026-06-30 |
| Vanguard Capital Management LLC | 2.11M | $76.0M | 3.62% | +2.7K | 2026-06-30 |
| Lsv Asset Management | 2.06M | $75.0M | 3.55% | +36.1K | 2026-06-30 |
| State Street Corp | 1.86M | $67.0M | 3.20% | +75.0K | 2026-06-30 |
| Armistice Capital, LLC | 1.56M | $56.0M | 2.69% | -60.0K | 2026-06-30 |
| Geode Capital Management, LLC | 1.44M | $52.0M | 2.48% | +119.9K | 2026-06-30 |